$CVS

just go into cvs and grab a garbage bag full of shit eh

Que tal! Soy nuevo por acá, recién terminando el curso.. como ven $CVS ? El sector no es el mejor, y no veo bien si hoy es entrada o no

2000 $CVS JUN2022 $105 Cs trade 1.2

2000 $CVS JUN2022 $105 Cs trade 1.2

Added small pos in CVS and ADSK to the new retirement acct. I like CVS but up against my yield fav ntdoy it’s not as good IMO

$CVS entre temprano hoy 🤑

CVS me la perdí hoy, pero si hace pullback tambien en la mira

400 $CVS 3SEP2021 $81 Cs bought 4.35

400 $CVS 3SEP2021 $81 Cs bought 4.35

UK Markets Finished higher yesterday, amid strong corporate earnings reports and helped by gains in financial sector stocks. Legal & General Group advanced 2.9%, as the company raised its interim dividend and reported an increase in profits in the first half of the year. Taylor Wimpey rose 1.9%, after the homebuilder reinstated its dividend and raised its annual guidance. Rolls-Royce Holdings edged up 1.4%, after the automaker announced that it would sell its Spain-based ITP Aero unit to US private equity firm Bain Capital and Spanish group Sener for €1.6 billion ($1.9 billion). On the flipside, Ferrexpo declined 9.3%, after the iron ore company reported that it expects demand for iron ore to decline in the second half of the year. Ryanair Holdings fell 0.6%. The airline operator announced that the number of passengers doubled in July. The FTSE 100 advanced 0.3%, to close at 7,123.9, while the FTSE 250 rose 0.3%, to end at 23,347.7. . European Market Closed higher yesterday, amid optimism over economic recovery and supported by gains in technology sector stocks. IMCD climbed 10.5%, after the chemicals distribution company reported upbeat results in the first half of the year. JDE Peet’s rose 2.4%, after the company reported stronger than expected operating profit in the first half of 2021. Thales edged up 0.2%, after the aerospace company announced that it would sell its railway signalling business to Hitachi for $2.0 billion. Hugo Boss gained 0.2%, after the fashion house reported better than expected revenue and earnings in the second quarter. On the other hand, Commerzbank dropped 5.8%, after the lender reported losses in the second quarter. Schaeffler fell 0.2%, even though the company reported upbeat results in the first of the year and lifted its guidance for 2021. The FTSEurofirst 300 index gained 0.6%, to settle at 1,804.9. The German DAX Xetra rose 0.9%, to settle at 15,692.1, while the French CAC-40 added 0.3%, to close at 6,746.2. . US Market Finished lower yesterday, following weaker than expected US employment data. General Motors plunged 8.9%, after the automaker reported lower than expected earnings in the second quarter. Kraft Heinz declined 5.1%, after the company reported a drop in quarterly organic net sales and sales volumes. Match Group dropped 5.0%, after the company issued disappointing earnings report in the second quarter. CVS Health fell 2.9%, even though the company reported better than expected revenue and earnings in the second quarter. On the other hand, Tupperware Brands advanced 4.3%, after the company reported stronger than expected second quarter earnings. Activision Blizzard rose 2.1%, after the video game company’s second quarter revenue and earnings surpassed analysts’ estimates. The S&P 500 slipped 0.5%, to settle at 4,402.7. The DJIA fell 0.9%, to settle at 34,792.7, while the NASDAQ added 0.1%, to close at 14,780.5. . Asian Market Are trading higher this morning. In Japan, Toyobo and Terumo have advanced 4.1% and 5.0%, respectively. Meanwhile, Konica Minolta and Isuzu Motors have dropped 2.1% and 3.4%, respectively. In Hong Kong, Alibaba Group Holding and Galaxy Entertainment Group have risen 1.8% and 2.8%, respectively. Meanwhile, PetroChina and Country Garden Services Holdings have fallen 2.1% and 5.7%, respectively. In South Korea, GS Retail and KCC have declined 3.3% and 3.7%, respectively. Meanwhile, LG Hellovision and NeXT Science have climbed 12.8% and 14.2%, respectively. The Nikkei 225 index is trading 0.3% higher at 27,678.8. The Hang Seng index is trading 0.1% up at 26,450.3, while the Kospi index is trading marginally lower at 3,279.2.

@Pyrognosis that turnaround on CVS. keep it that way 🤞🏾

Wednesday, August 4, 2021 Futures Up/Down % Last Dow -25.00 0.07% 34,973 S&P 500 -1.25 0.04% 4,413 Nasdaq 11.50 0.08% 15,058 U.S. S&P futures are flat heading into the trading day, looking to build on record highs from Tuesday as positive earnings boost U.S and European stocks while worries over China’s gaming and technology crackdown ease, helping lift those markets. Risk sentiment improves across Asia as Chinese and Hong Kong stocks push higher on tech recovery and solid Caixin PMI data. In Asian markets, The Nikkei Index fell -57 points to 27,854, the Shanghai Index rose 29 points to 3,477 and the Hang Seng Index jumped 231 points to settle at 26,426. In Europe, the German DAX is climbing around 125 points to 15,680, while the FTSE 100 is up 0.4% to 7,135. Chinese Jul Caixin Services PMI beat: 54.9 vs 50.6 consensus. Some also see the spread of the Covid-19 delta variant as delaying rather than stopping the economic recovery. The New York Times reported overnight that the FDA plans to give full approval to Pfizer (PFE) and BioNTech (BNTX) coronavirus vaccine by the start of the next month. Earnings season has been strong with about 87% of S&P 500 companies reporting earnings and revenue beats, according to FactSet. Just under 70% of the S&P 500 now has reported earnings. The S&P 500 closed at record highs with gains in Apple and healthcare stocks, as concerns over a surge in the Delta variant of the coronavirus was put to the back-burner, overshadowed by continued upbeat corporate earnings. Ten of the 11 S&P indexes traded higher, with energy stocks rebounding after getting hit by a dip in oil prices. Market Closing Prices Yesterday The S&P 500 Index gained 35.99 points, or 0.82%, to 4,423.15 The Dow Jones Industrial Average rose 278.24 points, or 0.80%, to 35,116.40 The Nasdaq Composite climbed 80.23 points, or 0.55%, to 14,761.29 The Russell 2000 Index advanced 8.09 points, or 0.36% to 2,223.58 Events Calendar for Today 7:00 AM ET MBA Mortgage Applications Data 8:15 AM ET ADP Employment Change for July…est. 695K 9:45 AM ET Markit Composite PMI, July-F 9:45 AM ET Markit Services PMI, July-F 10:00 AM ET ISM Non-Manufacturing Services PMI for July…est. 60.5 10:30 AM ET Weekly DOE Inventory Data Earnings Calendar: Earnings Before the Open: ABC, AEIS, ALE, APO, ASTE, BCOR, BDC, BGCP, BWA, CDW, CLVS, CLH, CLW, CMLS, CRL, CSII, DNOW, DOC, EDIT, EMR, ETR, EXC, FLOW, FUN, GEL, GM, HDSN, HFC, HZNP, IONS, JLL, KHC, LL, MAC, MKL, MPC, MPLX, MTOR, NI, NYT, ODP, RCL, SBGI, SGRY, SITE, SMG, SPR, SUP, TGI, TUP, TXMD, UTHR, VCEL, VMC, WLL Earnings After the Close: ACAD, ACLS, ADPT, ADTN, AGL, ALB, ALL, AMED, ANGI, ANSS, APA, ATO, AXGN, BBSI, BE, BFAM, BKNG, BOOT, CCMP, CDAY, CENX, CHNG, CMP, CPS, DGII, DOX, DVAX, DXC, EA, EGHT, ELF, EMKR, EOG, ETSY, EVH, FLT, FOXA, FSLY, FTDR, GDDY, GNK, HI, HUBS, IAC, INGN, IVR, JACK, LESL, LNC, LPI, LUMN, MAXR, MBI, MCK, MED, MET, MGM, MOD, MRO, MTG, NUS,NVRO, ONEM, PARR, PDCE, $PING, PLYA, QRVO, QTWO, RCII, REGI, RGR, RMAX, RNWK, EOKU, RPD, $RVLV, RYN, SBRA, SMSI, SUM, T$NDM, TPC, TTGT, TVTY, TWNK, TWO, TXG, $UBER, UHAL, VVV, VZIO, WDC, WU, YELL Other Key Events: Jefferies Industrials Conference (virtual), 8/3-8/4 Piper Wealth Management Forum (virtual), 8/3-8/6 Macro Up/Down Last Nymex -0.34 70.22 Brent -0.18 72.23 Gold 3.30 1,813.75 EUR/USD -0.0008 1.1856 JPY/USD 0.13 109.17 10-Year Note +0.008 1.182% Sector News Breakdown Consumer Caesar’s Entertainment ($CZR) Q2 EPS $0.34 vs. est. loss (-$0.26); Q2 revs $2.5B vs. est. $2.27B; Q2 same-store Adjusted EBITDA was $1B versus (-$131M) for the comparable prior-year period; Company posted all-time records in quarterly Adjusted EBITDA and Adjusted EBITDA margin. Denny’s ($DENN) Q2 adj EPS $0.18 vs. est. $0.11; Q2 revs $106.2M vs. est. $98.1M; Q2 domestic system-wide same-store sales decreased 1.2% compared to the equivalent fiscal period in 2019, including a 1.5% decrease at domestic franchised restaurants and a 1.9% increase at company restaurants. Herbalife ($HLF) Q2 adj EPS $1.52 vs. est. $1.29; Q2 revs $1.55B vs. est. $1.57B; Q2 adjusted EBITDA of $262.1M; raises FY21 EPS view to $4.70-$5.10 from $4.65-$5.05 (est. $4.93); sees FY net sales growth to be in a range of 8.5% to 12.5%, lowering the midpoint by 150 basis points compared to prior full year 2021 guidance. Host Hotels ($HST) Q2 adj FFO $0.12 vs. est. $0.04; Q2 revs $649M vs. est. $606.58M; said RevPAR reached nearly $100 for the quarter, which dramatically outperformed consensus RevPAR, with average room rates only 8.4% below our 2019 second quarter rates; not providing year guidance Hyatt ($H) 2Q adj EPS ($1.15) vs est. ($0.85) on comparable system-wide REVPAR $72.47, qtrly total revs $663Mm vs est. $686.9Mm; guides FY net rooms growth more than +6%, sees FY adj SG&A about $240Mm, sees FY CAPEX about $110Mm Energy Devon Energy ($DVN) Q2 adj EPS $0.60 vs est. $0.52 on revs $2.42B vs est. $2.35B, operating cash flow $1.1B, production for the quarter averaged 291k barrels/day; will pay total dividend of 49c/shr (11c fixed + 38c variable), a 44% increase from Q1; sees 3q production 566-594 mboe/d vs est. 564.80 mboe/d Occidental Petroleum ($OXY) Q2 adj EPS 32c vs est. 1c on revs $5.96B vs est. $5.92B, FCF $2B, cash flow from continuing operations $3.3B; said oil and gas results improved from Q1 due to higher commodity prices and sales volumes; executed debt tender offer and repaid over $3B of long-term debt in July ONEOK ($OKE) Q2 EPS $0.77 vs. est. $0.75; Q2 revs $3.39B vs. est. $3.03B; sees 2021 net income, adj earnings before interest, taxes, depreciation, amortization to be above midpoints of ranges provided on April 27, 2021 SunPower ($SPWR) Q2 adj EPS $0.06 vs. est. $0.04; Q2 revs $308.9M vs. est. $327.31M; guides Q3 revs $325M-$375M vs. est. $400.83M; sees Q3 GAAP net loss of $10 to $0 million and MW recognized of 125 MW to 150 MW; Q2 added 13,000 residential customers – residential bookings up 16 percent sequentially, 67 percent year-over-year (YoY) The American Petroleum Institute ($API) showed a draw of 879K barrels of oil for the latest week; gasoline inventories show a draw of 5.75M barrels, distillate inventories show a draw of 717K barrels and Cushing inventories show a build of 659K barrels W&T Offshore ($WTI) Q2 EPS $0.02 vs. est. $0.07; Q2 revs $132.8M vs. est. $122.38M; Q2 Production was 40,888 Boe/d or 3.7 MMBoe, an increase of 3% compared to 39,657 Boe/d in Q1 and down 3% versus 42,037 Boe/d in Q2 of 2020 Financials Assurant Inc. ($AIZ) Q2 operating EPS $2.99 vs. est. $2.45; Q2 revs $2.54B vs. est. $2.39B; continue to expect to grow eps, ex. catastrophes, by 10 to 14 percent for 2021 Fair Isaac ($FICO) Q3 non-GAAP EPS $3.38 vs. est. $2.76; Q3 revs $338M vs. est. $328.3M; Applications revenues, which include the company’s decision management applications and associated professional services, were $133.2 million in the third quarter, compared to $141.5 million in the prior year period, a decrease of 6% Genworth Financial ($GNW) Q2 adj EPS $0.38 vs. est. $0.22; Q2 revs $2.04B vs. est. $1.9B; planned IPO of Enact remains a key strategic objective for Genworth and is subject to market and other conditions, however because the company is in registration and subject to applicable publicity restrictions, is unable to comment further or provide any additional detail at this time. Green Dot ($GDOT) Q2 adj EPS $0.68 vs est. $0.43 on revs $369.4M vs est. $313.2M; sees FY21 adj EPS $2.13-$2.27 vs prev. $2.06-$2.15, revs $1.33B-$1.35B vs est. $1.28B Prudential ($PRU) Q2 adj EPS $3.79 vs. est. $3.02; qtrly book value per common share of $160.31 versus $165.53 per share for year-ago; qtrly adjusted book value per common share of $104.39 versus $92.07 per share for year-ago; qtr end assets under management of $1.730 trillion versus $1.605 trillion for year-ago; now expect to return a total of $11.0B to holders from $10.5B prior Tanger Outlets ($SKT) 2Q core FFO/shr $0.43 vs est. $0.28, portfolio occupancy was 93% on June 30 vs 91.7% on March 31, avg tenant sales productivity was $424/sq ft for 12 months ended June 30 +7.3% yr/yr; guides FY FFO/shr $1.52-1.59 vs est. $1.46 Unum Group (UNM) Q2 adj EPS $1.39 vs. est. $1.11; Q2 revs $2.99B vs. est. $2.96B; Full-year 2021 outlook increased; after-tax adjusted operating income per share now expected to decline 1%-3% relative to full-year 2020, compared to an expected decline of 5%-6% prior Verisk Analytics ($VRSK) Q2 adj EPS $1.17 vs. est. $1.33; Q2 revs $747.5M vs. est. $737.3M; Net cash provided by operating activities was $233.2 million, down 6.5% for the second quarter of 2021. Free cash flow, a non-GAAP measure, was $170.7 million, down 11.5% Healthcare Change Healthcare ($CHNG) shares fell over 7% on a report that the U.S. Dept. of Justice is considering a lawsuit to block the company’s $8B sale to UnitedHealth ($UNH) https://bit.ly/3yA4Etu Option Care Health ($OPCH) 18M share Spot Secondary priced at $20.25 Amgen Inc. ($AMGN) Q2 adj EPS $4.38 vs. est. $4.06; Q2 revs $6.5B vs. est. $6.43B; backs FY21 adj EPS view $16.00-$17.00 vs. est. $16.34; backs FY21 revenue view $25.8B-$26.6B vs. est. $26.04B Amid surge in new COVID-19 infections across U.S., the FDA plans to give full approval to Pfizer (PFE) – BioNTech (BNTX) coronavirus vaccine by the start of the next month, The New York Times reports The FDA classified the recent recall of some of Philips’ (PHG) ventilators as Class 1, or the most serious type of recall, saying the use of these devices may cause serious injuries or death – Reuters CVS Health ($CVS) Q2 adj EPS $2.42 vs. est. $2.06; Q2 revs $72.62B vs. est. $70.11B; raises FY21 adjusted EPS view to $7.70-$7.80 from $7.56-$7.68 (est. $7.66); sees FY21 cash flow from operations $12.5B-$13B DaVita Inc. (DVA) 2Q EPS $2.64 vs est. $2.17; says total US dialysis treatments for 2Q were 7,413497 (avg 95,045/day); guides FY adj EPS $8.80-9.40 vs est. $8.63, sees FY adj op income $1.8-1.875B vs est. $1.816B Inspire Medical ($INSP) 2Q EPS ($0.48) vs est. ($0.64) on revs $53Mm vs est. $43.9Mm; guides FY revs $210-213Mm vs est. $195.9Mm, sees FY gr mgn 85-86%, sees opening 48-52 new US medical centers per qtr for 2H Jazz Pharma ($JAZZ) Q2 adj EPS $3.90 vs. est. $3.42; Q2 revs $751.8M vs. est. $735.62M; reaffirms FY21 non-GAAP EPS view $13.40-$14.70 (est. $14.45) and also back FY21 revenue view $3.020B-$3.180B vs. est. $3.11B; as of June 30, cash, cash equivalents were $891.4 mln, and outstanding principal balance of co’s long-term debt was $7.1 bln

The S&P 500 index neared a record high on Monday as a $1 trillion infrastructure bill and strong second-quarter corporate earnings lifted sentiment ahead of a deluge of macroeconomic data this week. All 11 S&P indexes were trading higher, with consumer discretionary and financial stocks leading gains. Shares of Square Inc (NYSE:SQ), the payments firm of Twitter Inc (NYSE:TWTR) co-founder Jack Dorsey, rose 3.6% after it said it would purchase Australian buy now, pay later pioneer Afterpay Ltd for $29 billion. Afterpay's Australia-listed stock surged 18.8%. Trillions of dollars in stimulus have lifted Wall Street to record highs following the coronavirus-driven crash last year, while upbeat second-quarter corporate earnings led the S&P 500 to its sixth monthly gain in a row in July despite the growing threat from the Delta variant of the coronavirus. The rebound in corporate profits and a recent drop in bond yields have also helped to moderate U.S. equity valuations, bolstering the case further for owning stocks. "The second-quarter earnings season has been nothing short of spectacular," said Art Hogan, chief market strategist at National Securities in New York. "We would recommend a diversified equity allocation with a barbell approach that has growth exposure on one end and economically sensitive cyclical exposure on the other." The S&P value index, which houses economy-linked stocks including industrials, energy and financials, rose 0.5% last week, far outperforming a 1.1% drop in the S&P growth index. At 9:33 a.m. ET, the Dow Jones Industrial Average was up 0.45%. The S&P 500 was up 0.53% and the Nasdaq Composite was up 0.48%, both boosted by heavyweight technology stocks. " onerror="this.style.display='none'" class="msg-img" /> Shares of infrastructure-related stocks including Caterpillar Inc (NYSE:CAT) inched higher as the Senate on Sunday unveiled the $1 trillion bipartisan plan to invest in roads, high-speed internet and other infrastructure. Focus now turns to business activity data and the Labor Department's monthly jobs report this week against the backdrop of fears the fast-spreading Delta variant could hit growth in the second half of the year. "I don't think investors are worried about broader macroeconomic numbers even if they are showing signs of a slowdown; the concern lies in the risk of reopening being on pause because of the spread of the Delta variant," said Dennis Dick, a proprietary trader at Bright Trading LLC. After mixed quarterly reports from technology behemoths last week, all eyes this week are on earnings from companies including Eli Lilly (NYSE:LLY) and Co, CVS Health Corp (NYSE:CVS) and General Motors Co (NYSE:GM). Shares of ride hailing firms Uber Technologies (NYSE:UBER) Inc and Lyft Inc (NASDAQ:LYFT) rose about 1% ahead of their second-quarter results this week, where investors will look for comments on how an ongoing driver shortage and the Delta variant were clouding the outlook for the year. Advancing issues outnumbered decliners 3.11-to-1 on the NYSE and 2.68-to-1 on the Nasdaq. The S&P index recorded 49 new 52-week highs and two new lows, while the Nasdaq recorded 43 new highs and 10 new lows.

SCAN RESULTS - BULLISH BOTTOMS $DISCA, $CHGG, $STNE, $ATVI, $PSX, $AZEK, $ETSY, $FTCH, $POSH, $UAA, $SNAP, $PFGC, $BMRN, $CAT, $BIGC, $AVLR, $RSX, $BKR, $COUP, $STNE, $LI, $LESL, $BMBL, $PTON, $IOVA, $RUBY TOPS $ATVI, $FTCH, $FVRR, $IFT, $SBH, $SONY, $YUM, $CVS, $NVST, $CAT, $SYK, $TDC, $TWLO, $RSX, $AMZN, $ALXN BEARISH $BK, $ELS, $KMX, $MCK, $NIO, $WFC, $NVDA, $TLT, $VALE, $INFY

Here is the focus list - $SNOW, $THO, $SLB, $LMND, $SQ, $CAR(EARLY on the Fence) Runners Up Have Potential: $SPCE, $PDD, $BIDU, $CVS, $RBLX, $CARV, $CVNA, Keep an Eye on these: $GRPN, $EAR, $CALX, $KMX, $ATHM

here is what I am in currently I have been testing this week . Trying to find strikes that are good for the challenge, we can't trade large caps out of the gate. have to build into those $1 contracts. $CVS, $SLB, $VUZI <- swing on $VUZI

US Markets Closed lower yesterday, amid losses in technology sector stocks. Smile Direct Club plunged 19.0%, after the company warned that its current quarter sales will be affected by an April cyberattack, costing it between $10.0 million and $15.0 million. iRobot declined 7.5%, amid concerns about shipping and component costs. Meanwhile, Domtar jumped 19.2%, following reports that Canada’s Paper Excellence is exploring a deal to buy its US-based paper and packaging rival. Vaxart climbed 9.2%, after the company reported positive results in a phase 1 trial of its oral Covid-19 vaccine. CVS Health advanced 4.4%, after the company’s first quarter revenue and earnings came in above analyst forecast. Quest Diagnostics added 2.8%, after a top broker upgraded its rating on the stock to ‘Buy’ from ‘Neutral’. The S&P 500 slipped 0.7%, to settle at 4,164.7. The DJIA rose 0.1%, to settle at 34,133.0, while the NASDAQ shed 1.9%, to close at 13,633.5.

out $CVS aug calls for now 5.8 to 9.4

CVS is best stock in the world > @Benlax said: $CVS today

1700 $CVS 06-17 P $82.5 ( 1.7mil)

1846 $CVS JUN2021 $80 Cs bought 2.52-2.56

1846 $CVS JUN2021 $80 Cs bought 2.52-2.56

PFE CVS and CRSR out of the larger names reported ER this morning

$PFE, $CVS, $BG, $UAA higher on earnings

CVS Health Q121 Earnings: Revenue: $69.10B (est $68.46B) Adj EPS: $2.04 (est 1.71) Sees FY Adj EPS: $7.56 To $7.68 (saw: $7.39 To $7.55) Comp Sales: +0.4%

no positions in that, but have CVS equity. very old position > @Snowcow said: yah pypl,sq this week also. got some bigger ones this week

yeah > @Jonove said: Did CVS push hard on giving vaccines?

Did CVS push hard on giving vaccines?

CVS er tomorrow morning 🤞🏾

That CVS hitting new 52 week highs right before er

$WBA $CVS also in that party

CVS is love of my life

$CVS looks like a breakout candidate

DA CcCcCcccccCCzzz > @AJAJ said: C, CVS, COST lol

LOL > @AJAJ said: C, CVS, COST lol

C, CVS, COST lol

rolled pins to may and cvs to aug

its because of the alliance > @Benlax said: WBA up 6% and CVS down wtf..

WBA up 6% and CVS down wtf..

CVS having a hell of a day .. go baby go

CVS 75s ITM now

$CVS good so far

My current market thesis: Tech could continue to be weak (don't expect anything big cause its already corrected a lot) over the next few months so my favorite is consumer discretionary: LVMUY NKE SMG LOW must owns. Also YETI is actually great if you got $. Other than that CARR and CVS good safety names (I actually think you could see CVS double over the next year or two), would definitely own some CARR. AXON nice nontech growth name off its highs. Also with housing so hot, realtors Z/RDFN/EXPI are great (i own RDFN and have EXPI calls). TREX also a great play for housing. Lastly, reallyyyy like SNE here Market is setting up to potentially get pretty crazy to the upside actually i think especially if yields stay under control value/growth rotation is largely over so you wont see as bifurcated markets and its gonna be more a stock pickers market. Big winners in both baskets

fwiw looking like $CVS gonna close above downtrend line. I got a couple AUG 70 calls

CVS going to reprice imo reducing debt by 10% /year they'll go from 70B to 30B by 2025 should be doing $10-11 in EPS in 2024-2025 assuming they up dividend payout ratio from ~25% to 50% as the balance sheet improves, could see a $5 dividend then 10-15% FCF yield lol you're either getting the retail business or the insurance company for free, not sure which haha i've been buying since the 50's but thinking next leg to 80 more likely than 60 may swing harder despite balking the other day other 70

CVS going to reprice imo reducing debt by 10% /year they'll go from 70B to 30B by 2025 should be doing $10-11 in EPS in 2024-2025 assuming they up dividend payout ratio from ~25% to 50% as the balance sheet improves, could see a $5 dividend then

on cvs commonking on ST had some comments on it today

1015 $CVS MAY2021 $72.5 Cs bought 3.7

1015 $CVS MAY2021 $72.5 Cs bought 3.7

dope > @dros said: LYFT TEAMS UP WITH CVS HEALTH TO SUPPORT EQUITABLE ACCESS TO THE COVID-19 VACCINE